Dr Martin O'Kane

Regional Head of Regulatory Affairs EU Policy & Liaison, Novartis Pharmaceuticals

Martin O’Kane PhD is Regional Head of Regulatory Affairs EU Policy & Liaison at Novartis Pharmaceuticals, responsible for developing and implementing complex regulatory strategies in global development and enabling regulatory compliance. He is co-chair of the European Federation of Pharmaceutical Industries Associations (EFPIA) Clinical Trials Regulation Pillar and is a member of the BIA Regulatory Affairs Advisory Committee. Martin has seventeen years’ previous experience in medicines regulation working in the Medicines and Healthcare products Regulatory Agency (MHRA), the majority of which was in the clinical trials field including scientific assessment of trial applications and development of policy, guidance, and legislation relevant to the UK’s exit from the EU and the UK response to COVID-19.

Professor Manohar Bance

Professor of Otology and Skull Base Surgery, University of Cambridge

Professor  Bance is the Professor of Otology and Skull Base Surgery at the University of Cambridge. Prior to 2017, he was Chair of the Dept of Otolaryngology, Dalhousie University in Canada.  He is a surgeon-scientist, who runs a basic science lab. He also runs a genetic hearing loss clinic, and has been involved with first in human studies for gene therapy for hearing loss